Lilie L Lin

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Combined modality therapy in the elderly population
    Lilie L Lin
    Department of Radiation Oncology, University of Pennsylvania, 3400 Spruce Street, 2 Donner Building, Philadelphia, PA 19104, USA
    Curr Treat Options Oncol 10:195-204. 2009
  2. ncbi Long-term outcome in children treated for craniopharyngioma with and without radiotherapy
    Lilie L Lin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Neurosurg Pediatr 1:126-30. 2008
  3. ncbi FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer
    Lilie L Lin
    Department of Radiation Oncology, Department of Radiology, Mallinckrodt Institute of Radiology, St. Louis, MO, USA
    Int J Radiat Oncol Biol Phys 65:177-81. 2006
  4. ncbi Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer
    Agnes Y Bahng
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Int J Radiat Oncol Biol Phys 82:667-73. 2012
  5. ncbi Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies
    Abigail Berman Milby
    Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Int J Radiat Oncol Biol Phys 82:e477-84. 2012
  6. ncbi External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer
    Lilie L Lin
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 106:215-20. 2007
  7. ncbi Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients
    Lilie L Lin
    Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Cancer Biother Radiopharm 27:412-9. 2012
  8. ncbi A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response
    Ramesh Rengan
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Thorac Oncol 7:709-15. 2012
  9. ncbi Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques
    Christine E Hill-Kayser
    Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Thorac Oncol 4:1431-7. 2009
  10. ncbi Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance
    Lilie L Lin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Int J Radiat Oncol Biol Phys 83:670-5. 2012

Detail Information

Publications17

  1. ncbi Combined modality therapy in the elderly population
    Lilie L Lin
    Department of Radiation Oncology, University of Pennsylvania, 3400 Spruce Street, 2 Donner Building, Philadelphia, PA 19104, USA
    Curr Treat Options Oncol 10:195-204. 2009
    ..Investigators should be encouraged to expand eligibility to include elderly patients on non age-related clinical trials. Additionally, therapy-related clinical trials directed at the elderly should be developed...
  2. ncbi Long-term outcome in children treated for craniopharyngioma with and without radiotherapy
    Lilie L Lin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Neurosurg Pediatr 1:126-30. 2008
    ..The authors report the results of surgery alone or in combination with radiotherapy in the management of craniopharyngiomas in children...
  3. ncbi FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer
    Lilie L Lin
    Department of Radiation Oncology, Department of Radiology, Mallinckrodt Institute of Radiology, St. Louis, MO, USA
    Int J Radiat Oncol Biol Phys 65:177-81. 2006
    ..9 Gy. CONCLUSION: These results indicate that physiologic tumor volume determination by FDG-PET is feasible and that a 50% physiologic tumor volume reduction occurs within 20 days of starting therapy...
  4. ncbi Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer
    Agnes Y Bahng
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Int J Radiat Oncol Biol Phys 82:667-73. 2012
    ..Secondary goals of this study included a quantitative assessment of optimal dilator use frequency and a crude assessment of clinical predictors for compliant dilator use...
  5. ncbi Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies
    Abigail Berman Milby
    Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Int J Radiat Oncol Biol Phys 82:e477-84. 2012
    ....
  6. ncbi External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer
    Lilie L Lin
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 106:215-20. 2007
    ..To determine if brachytherapy alone is adequate adjuvant local therapy in patients classified as intermediate risk after complete surgical staging for endometrioid adenocarcinoma...
  7. ncbi Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients
    Lilie L Lin
    Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Cancer Biother Radiopharm 27:412-9. 2012
    ..As with any radiotracer with primary excretion in the urine, the bladder-wall dose can be minimized by active hydration and frequent voiding...
  8. ncbi A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response
    Ramesh Rengan
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Thorac Oncol 7:709-15. 2012
    ....
  9. ncbi Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques
    Christine E Hill-Kayser
    Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Thorac Oncol 4:1431-7. 2009
    ....
  10. ncbi Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance
    Lilie L Lin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Int J Radiat Oncol Biol Phys 83:670-5. 2012
    ..To determine the impact of body mass index (BMI) on daily setup variations and frequency of imaging necessary for patients with endometrial cancer treated with adjuvant intensity-modulated radiotherapy (IMRT) with daily image guidance...
  11. ncbi A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma
    Lilie L Lin
    Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA
    Am J Clin Oncol 28:234-41. 2005
    ..Despite the prolongation in radiation treatment time because of split-course treatment, patients with sufficient response were able to undergo resection...
  12. ncbi Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix
    Lilie L Lin
    Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 63:1494-501. 2005
    ..CONCLUSIONS: Sequential FDG-PET brachytherapy imaging identifies the tumor response in individual patients, potentially making patient-specific brachytherapy treatment planning possible...
  13. ncbi Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma
    Agnes Y Bahng
    Department of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
    J Gynecol Oncol 23:257-64. 2012
    ..To determine risk factors associated with recurrence in patients with high intermediate risk (HIR) endometrioid adenocarcinoma...
  14. ncbi Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity
    John B Liao
    Division of Gynecologic Oncology, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Gynecol Oncol 120:108-12. 2011
    ..Vaginal dysplasia is associated with prior radiation therapy (RT) for gynecologic malignancies. We reviewed our institution's experience with VAIN in patients who were treated with radiation therapy for a gynecologic malignancy...
  15. ncbi Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET
    Lilie L Lin
    Radiation Oncology Department, Mallinckrodt Institute of Radiology, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 67:91-6. 2007
    ..A dosimetric study was conducted to compare intracavitary brachytherapy using both a conventional and a custom loading intended to cover a positron emission tomography (PET)-defined tumor volume in patients with cervix cancer...
  16. ncbi F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy
    Feiyu Xue
    Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
    Gynecol Oncol 101:147-51. 2006
    ..High FDG uptake may be useful in identifying patients who may require more aggressive initial therapy...
  17. ncbi Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer
    Lilie L Lin
    Department of Radiation Oncology, Washington University Medical School, 4921 Parkview Place, St. Louis, MO 63110
    Int J Radiat Oncol Biol Phys 63:500-4. 2005
    ..Radiotherapy is well tolerated, with a low risk of complications. Factors predictive of overall survival include tumor grade, patient age at recurrence, and tumor size...